DNA methyltransferases such as DNMT3 and DNMT1 may mediate the cardiac remodelling in the development of heart failure through de novo methylation of DNA of non-coding regions, with impacts on the genetic expression of proteins with significant roles, such as MYH7, MYH6 and MMP9. This evidence concerns the gene MMP9 and heart failure.